Cargando…

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)

BACKGROUND AND AIMS: Erythropoietin (EPO) is a glycoprotein hormone which is required to regulate the production of red blood cells. Deficiency of EPO is known to cause anemia in chronically infected renal patients and they require regular blood transfusion. Availability of recombinant EPO has elimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kausar, Humera, Gull, Sana, Ijaz, Bushra, Ahmad, Waqar, Sarwar, Muhammad Tahir, Iqbal, Zafar, Nawaz, Zafar, Riazuddin, Sheikh, Hassan, Sajida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228713/ https://www.ncbi.nlm.nih.gov/pubmed/22040235 http://dx.doi.org/10.1186/1479-5876-9-186

Ejemplares similares

Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell
por: Asad, Sultan, et al.
Publicado: (2012)

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
por: Ahmad, Waqar, et al.
Publicado: (2011)

Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation
por: Ahmad, Waqar, et al.
Publicado: (2011)

A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation
por: Ahmad, Waqar, et al.
Publicado: (2011)

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
por: Sarwar, Muhammad T, et al.
Publicado: (2011)

Association of laboratory parameters with viral factors in patients with hepatitis C
por: Ijaz, Bushra, et al.
Publicado: (2011)

Serine 204 phosphorylation and O-β-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma
por: Ahmad, Waqar, et al.
Publicado: (2011)

Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line
por: Jahan, Shah, et al.
Publicado: (2011)

Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers
por: Ijaz, Bushra, et al.
Publicado: (2011)

A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)
por: Ahmad, Waqar, et al.
Publicado: (2011)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
por: Ahmad, Waqar, et al.
Publicado: (2012)

Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
por: Trincavelli, Maria Letizia, et al.
Publicado: (2013)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2018)

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2019)

Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis
por: Jahan, Shah, et al.
Publicado: (2011)

Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
por: Song, Kwang-Eun, et al.
Publicado: (2014)

Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA
por: Ansar, Muhammad, et al.
Publicado: (2011)

In-vitro model systems to study Hepatitis C Virus
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

Inhibition of Hepatitis C Virus 3a genotype entry through Glanthus Nivalis Agglutinin
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

An overview of HCV molecular biology, replication and immune responses
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Inhibition of HCV 3a core gene through Silymarin and its fractions
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

HCV infection causes cirrhosis in human by step-wise regulation of host genes involved in cellular functioning and defense during fibrosis: Identification of bio-markers
por: Ijaz, Bushra, et al.
Publicado: (2019)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients
por: Dwitanto, Kuspuji, et al.
Publicado: (2023)

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
por: Lamon, Séverine, et al.
Publicado: (2013)

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
por: Wang, Guan, et al.
Publicado: (2017)

Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes
por: Montesano, Alberto, et al.
Publicado: (2019)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t0scp7be0u1aengdief5s0tl8d